Strong Revenue Growth
RadNet reported total company revenue of $471.4 million, a 9.2% increase from the first quarter of 2024, despite weather-related impacts.
Advanced Imaging Growth
Advanced Imaging procedural volume increased to 26.9% from 25.7% year-over-year, supported by investments in equipment.
PET/CT Volumes Increase
PET/CT volumes increased 22.9%, driven by newer prostate and brain procedures.
Digital Health Revenue Increase
The Digital Health segment reported revenue of $19.2 million, up 31.1% from the first quarter of 2024.
Strong Liquidity Position
RadNet ended the quarter with a cash balance of $717 million and a net debt to adjusted EBITDA ratio of slightly more than one.
EBCD Program Growth
The EBCD digital DeepHealth AI-powered breast cancer screening program revenue increased by 33% year-over-year.